In 2012 Jennifer Doudna and Emmanuelle Charpentier and their teams published a paper showing that the bacterial CRISPR-Cas9 system could be directed to cut DNA at a chosen location.
Other researchers soon showed it worked in human cells. Doudna and Charpentier received the 2020 Nobel Prize in Chemistry.